MEI Pharma, Inc. (MEIP) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1157103,
    "name": "MEI Pharma, Inc.",
    "stock_name": "MEI Pharma, Inc.",
    "full_name": "MEI Pharma, Inc.",
    "name_url": "stocks-analysis/mei-pharma-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.75",
    "chg": -0.05,
    "chgp": "-2.78%",
    "dir": -1,
    "prev_price": "1.80",
    "mcapval": "98.51",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US55279B3015",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "699.38 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mei-pharma-inc-1157103-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is MEI Pharma, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mei-pharma-inc-technically-bullish-or-bearish-3546362",
        "imagepath": "",
        "date": "2025-09-20 19:30:44",
        "description": "As of 4 September 2025, the technical trend for MEI Pharma, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, which supports the overall mildly bullish stance. However, the Bollinger Bands are bearish on both weekly and monthly time frames, suggesting potential downward pressure. The KST shows bullish momentum on both weekly and monthly charts, and the OBV is bullish on a monthly basis, indicating accumulation. \n\nIn terms of performance, MEI Pharma has underperformed the S&P 500 across multiple periods, with a significant decline of 72.90% over the last 3 years compared to a 70.41% gain in the S&P 500. Overall, the current technical stance is mildly bullish, but the strength is tempered by bearish indicators in the Bollinger Bands and mixed MACD signals...."
      },
      {
        "title": "Is MEI Pharma, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mei-pharma-inc-overvalued-or-undervalued-3542950",
        "imagepath": "",
        "date": "2025-09-20 18:06:49",
        "description": "As of 8 July 2024, MEI Pharma, Inc. has moved from a very attractive valuation grade to one that does not qualify. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.74 and an EV to EBITDA ratio of 0.27, which indicate a lack of profitability and efficiency in generating earnings relative to its enterprise value. Additionally, the ROE stands at -106.26%, highlighting significant losses relative to shareholder equity.\n\nIn comparison to its peers, MEI Pharma, Inc. shows a less favorable position, with Immunic, Inc. having a P/E ratio of -0.8008 and Adicet Bio, Inc. at -0.5353, suggesting that while all companies are struggling, MEI's valuation metrics are particularly concerning. The stock has underperformed significantly against the S&P 500, with a 1Y return of -10.86% compared to the index's 17.14%, and a staggering -96.17% over the last 5 years, rei..."
      }
    ],
    "total": 7,
    "sid": "1157103",
    "stock_news_url": "https://www.marketsmojo.com/news/mei-pharma-inc-1157103"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is MEI Pharma, Inc. technically bullish or bearish?

2025-09-20 19:30:44

As of 4 September 2025, the technical trend for MEI Pharma, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish, indicating mixed signals. The daily moving averages are mildly bullish, which supports the overall mildly bullish stance. However, the Bollinger Bands are bearish on both weekly and monthly time frames, suggesting potential downward pressure. The KST shows bullish momentum on both weekly and monthly charts, and the OBV is bullish on a monthly basis, indicating accumulation. In terms of performance, MEI Pharma has underperformed the S&P 500 across multiple periods, with a significant decline of 72.90% over the last 3 years compared to a 70.41% gain in the S&P 500. Overall, the current technical stance is mildly bullish, but the strength is tempered by bearish indicators in the Bollinger Bands and mixed MACD signals....

Is MEI Pharma, Inc. overvalued or undervalued?

2025-09-20 18:06:49

As of 8 July 2024, MEI Pharma, Inc. has moved from a very attractive valuation grade to one that does not qualify. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.74 and an EV to EBITDA ratio of 0.27, which indicate a lack of profitability and efficiency in generating earnings relative to its enterprise value. Additionally, the ROE stands at -106.26%, highlighting significant losses relative to shareholder equity. In comparison to its peers, MEI Pharma, Inc. shows a less favorable position, with Immunic, Inc. having a P/E ratio of -0.8008 and Adicet Bio, Inc. at -0.5353, suggesting that while all companies are struggling, MEI's valuation metrics are particularly concerning. The stock has underperformed significantly against the S&P 500, with a 1Y return of -10.86% compared to the index's 17.14%, and a staggering -96.17% over the last 5 years, rei...

View All News